Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Utpal Koppikar currently holds 32,500 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Utpal Koppikar has been a net seller of ATRA stock. They have purchased $105.3K and sold $705.4K worth of shares.
Utpal Koppikar's most recent insider trade was on Jun 20, 2024, when they sold 32,500 shares at $0.00 per share.
Utpal Koppikar serves as Executive at Atara Biotherapeutics, Inc. (ATRA). They have executed 33 insider transactions totaling $810.7K over their tenure at the company.
Utpal Koppikar holds the position of Executive at Atara Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Utpal Koppikar has shown a selling trading pattern, with $105.3K in total purchases and $705.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Utpal Koppikar was on Jun 8, 2021, when they sold $81.8K worth of ATRA shares. This transaction involved 5,820 shares at $14.06 per share.
Utpal Koppikar currently owns 32,500 shares of Atara Biotherapeutics, Inc. (ATRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Utpal Koppikar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Utpal Koppikar has 33 Form 4 filings on record as an insider at Atara Biotherapeutics, Inc..
Set alerts for Utpal Koppikar and 40,000+ other insiders.